Longevity and Age-Related Disease Consultancy

Overview

CortexBio offers specialised consulting services that focus on the intersection of ageing biology and disease mechanisms, enabling clients to navigate this rapidly evolving field effectively. We translate cutting-edge longevity science into practical applications for therapeutic development, biomarker discovery, and clinical trial design.

Our Approach

We combine deep scientific expertise with strategic business acumen to help companies leverage advances in ageing research. Our services include:

·      Longevity Science Translation: Interpret complex ageing research for practical application in drug development and healthcare.

·      Age-Related Disease Strategy: Develop targeted approaches for diseases of ageing that incorporate the latest scientific understanding.

·      Longevity Biomarker Identification: Identify and validate biomarkers that can accelerate clinical development in age-related conditions.

·      Cross-Therapeutic Opportunities: Uncover shared mechanisms between ageing and specific diseases that create new therapeutic possibilities.

Benefits

·      Access to cutting-edge scientific insights translated for practical application

·      Identification of novel therapeutic targets and approaches

·      Strategic positioning in the rapidly growing longevity sector

·      Cross-disciplinary perspectives that reveal new opportunities

Why CortexBio

Our "metabolic mosaic" framework uniquely positions us to identify connections between ageing processes and specific disease mechanisms. Dr. Martini-Drew's extensive experience in both rare diseases and metabolic health provides a distinctive perspective on how these fields intersect with longevity science.